|
|
Komipharm International Co Ltd
KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 10/28/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization808,650 mln
Float42.45 mln
Earnings Date08/19/2025
Pre-Tax Margin
-6%
Marginally loss-making
Key Fundamentals
EPS-35.91
ROE-3.63
ROIC0.90
ROA-1.90
Interest Cover0.45
EBITDA, mln1,747
EV / EBITDA417
EV / EBIT-663
Revenue, mln53,018
EV / Revenue13.74
Quote Details
Last
8,680.00
Change
390 (4.7%)
Open
8,360.00
Volume
178,260
Turnover
1,547,296,768
Average Volume
308,173
Financial Ratios
Pre-Tax Profit Margin-6
Current Ratio1.31
Price / Book9.52
Price / Tangible Book10.48
Debt / Equity0.58
Price / Sales13.28
Financial Strength
Altman Z-Score6.92
Piotroski F-Score
4
/ 9
Beneish M-Score-2.54
Price to Intrinsic Value14.20
Price to Graham Number15.52
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-8.73% |
9
/ 100
 |
| 1 Month |
-11.88% |
28
/ 100
 |
| 2 Months |
19.23% |
89
/ 100
 |
| 6 Months |
-9.87% |
70
/ 100
 |
| 1 Year |
36.05% |
86
/ 100
|
|
| |
